Century Therapeutics, Inc. Common Stock (IPSC) is a publicly traded Healthcare sector company. As of May 21, 2026, IPSC trades at $2.25 with a market cap of $411.21M and a P/E ratio of -15.75. IPSC moved +6.37% today. Year to date, IPSC is +126.27%; over the trailing twelve months it is +275.00%. Its 52-week range spans $0.34 to $3.04. Analyst consensus is strong buy with an average price target of $5.20. Rallies surfaces IPSC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own IPSC include Panagora Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Century Therapeutics, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $2.25 |
| Market Cap | $411.21M |
| P/E Ratio | -15.75 |
| EPS | $-0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.04 |
| 52-Week Low | $0.34 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $109.16M |
| Net Income | $-9.58M |
| Gross Margin | 0.00% |
4 analysts cover IPSC: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.20.